期刊文献+

升压物质检查法在药品生物安全性检查中的应用及实验关键点

Application of Vasopressor Activity Test in Drug Biological Safety Tests and Analysis of Experimental Key Points
下载PDF
导出
摘要 升压物质检查法是《中国药典》收录的一项药物安全性检查法。用以检测可能含有引起血压升高杂质的原料药及其制剂中升压物质的限度是否符合标准规定。该检查法的使用范围虽然较窄,但在临床用药安全上发挥着重要作用。本文就升压物质检查法的实验原理、实验系统、方法应用、各国药典收录情况、改进建议,以及实验要点进行综述,为相关实验人员提供参考。 The vasopressor activity test is one of the drug biological safety test method included in the Chinese Pharmacopoeia.It is used to detect whether the limits of vasopressor in APIs and related preparations that may contain impurities which may raise blood pressure meet the standard requirements.Although the application of this test is narrow,it plays an important role in the safety of clinical treatment.This article summarizes the experimental principles,experimental systems,method applications,improvement suggestions,and experimental key points of the vasopressor activity test,so that provides references for relevant experimenters.
作者 张媛 郭龙静 吴彦霖 杨泽岸 纳涛 ZHANG Yuan;GUO Longjing;WU Yanlin;YANG Ze’an;NA Tao(National Institutes for Food and Drug Control,Beijing 102629,China)
出处 《实验动物科学》 2024年第3期90-94,共5页 Laboratory Animal Science
关键词 升压物质检查法 升压素 血压 生物安全性检查 vasopressor activity test vasopressin blood pressure biological safety tests
  • 相关文献

参考文献11

二级参考文献57

  • 1Boyle WA Ⅲ, Segel LD. Direct cardiac effects of vasopressin and their reversal by a vascular antagonist[J]. Am J Physiol, 1986,251: H734-H741.
  • 2Zenteno-Savin T, Sada-Ovalle I, Ceballos G, et al. Effects of arginine vasopressin in the heart are mediated by specific intravascular endothelial receptors[J]. Eur J Pharmacol, 2000, 410:15-23.
  • 3Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock [ J ]. Circulation,1997, 95:1122-1125.
  • 4Gold J, Cullinane S, Chen J, et al. Vasopressin in the treatment of milrinone induced hypotension in severe heart failure [J ]. Am J Cardiol, 2000, 85: 506-508.
  • 5Dunser MW, Mayr AJ, Stallinger A, et al. Cardiac performance during vasopressin infusion in postcardiotomy shock[J ]. Intensive Care Med, 2002, 28: 746-751.
  • 6Boyle WA, Segel LD. Attenuation of vasopressin-mediated coronary constriction and myocardial depression in the hypoxic heart [J ]. Circ Res, 1990, 66: 710-721.
  • 7Sharshar T, Carlier R, Blanchard A, et al. Depletion of neurohypophyseal content of vasopressin in septic shock [J ]. Crit Care Med, 2002, 30: 497-500.
  • 8Landry DW, Levin HR, Gallant EM, et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock[J ]. Crit Care Med,1997, 25:1279-1282.
  • 9Lindner KH, Dirks B, Strohmenger HU, et al. Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation[ J ]. Lancet, 1997, 349: 535-537.
  • 10Tsuneyoshi I, Yamada H, Kakihana Y, et al. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock[ J ]. Crit Care Med, 2001,29: 487.

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部